Selenium Not Linked to Recurrence of Non-Muscle-Invasive Bladder Cancer
WEDNESDAY, Oct. 18, 2023 (HealthDay News) -- For patients with non-muscle-invasive bladder cancer (NMIBC), selenium supplementation does not reduce the risk for recurrence, while vitamin E is associated with an increased risk for recurrence, according to a study published online Oct. 17 in JAMA Network Open.
Richard T. Bryan, Ph.D., from the University of Birmingham in the United Kingdom, and colleagues conducted a multicenter study involving patients with newly diagnosed NMIBC recruited from 10 secondary or tertiary care hospitals. Two hundred seventy patients were randomly assigned to selenium plus placebo, vitamin E plus placebo, selenium plus vitamin E, and placebo plus placebo in a double-blind manner (65, 71, 69, and 65 patients, respectively).
The median overall follow-up was 5.5 years; 84 percent were followed for more than five years. The median treatment duration was 1.5 years. Due to slow accrual, the study was halted. The researchers observed no difference in the recurrence-free interval (RFI) for selenium versus no selenium. A statistically significant detriment to RFI was seen for vitamin E versus no vitamin E. Significant differences were not observed with either supplement for the progression-free interval or overall survival time. After regression modeling to adjust for known prognostic factors, results were unchanged. A total of 1,957 adverse events were reported, including 85 serious; all appeared to be unrelated to trial treatment.
"These findings suggest that vitamin E supplementation may be harmful to patients with NMIBC, and elucidation of the underlying biology is required," the authors write.
One author disclosed ties to Cystotech.
Related Posts
Una prueba de sangre muestra potencial para la detección temprana del cáncer
LUNES, 12 de septiembre de 2022 (HealthDay News) -- Una sola prueba de sangre...
Study Probes Links Between Vaccines and Asthma in Kids, With Inconclusive Results
WEDNESDAY, Sept. 28, 2022 (HealthDay News) -- Aluminum in childhood vaccines has...
New COVID-19 Drug Guards Against All Variants in Immunocompromised
FRIDAY, April 28, 2023 (HealthDay News) -- A new antibody drug to help fight...
More Older Americans Use Online Patient Portals to Access Care
WEDNESDAY, May 24, 2023 (HealthDay News) -- Older Americans are increasingly...